Talphera Inc - Company Profile
Powered by 
All the data and insights you need on Talphera Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Talphera Inc Strategy Report
- Understand Talphera Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Talphera Inc (Talphera), formerly AcelRx Pharmaceuticals Inc (AcelRx), is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain. The company’s lead product candidate, Dsuvia (known as Dzuveo in Europe), is a single sufentanil sublingual tablet for treating of moderate-to-severe acute pain. Its pipeline also includes Zalviso (for US market), a drug and device combination product for the management of moderate to severe acute pain in adults. Talphera developed a proprietary, non-invasive, sublingual formulation technology to deliver its highly lipophilic drugs. Talphera is headquartered in Hayward, California, the US.
Headquarters
United States of America
Address
1850 Gateway Drive, Suite 175, San Mateo, California, 94404
Website
www.acelrx.com
Telephone
1 650 2163500
No of Employees
15
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
TLPH (NASD)
Revenue (2022)
$651,000
EPS
XYZ
Net Income (2022)
XYZ
-138.5%
(2022 vs 2021)
Market Cap*
$19.0M
Net Profit Margin (2022)
XYZ
-279.0%
(2022 vs 2021)
* As of and is in US$
Talphera Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Zalviso - For Moderate to Acute Pain | Zalviso |
| Dsuvia (Dzuveo) - For Moderate to Acute Pain | Dsuvia |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Corporate Changes/Expansions | In January, the company changed its name to Talphera Inc. |
| 2023 | Divestiture | In March, the company announced the divestment of its FDA-approved drug, DSUVIA to Alora Pharmaceuticals (Alora). |
| 2022 | Acquisitions/Mergers/Takeovers | In January, the company acquired the US-based Lowell Therapeutics. |
Competitor Comparison
| Key Parameters | Talphera Inc | Collegium Pharmaceutical Inc | BioDelivery Sciences International Inc | Cara Therapeutics Inc | Acura Pharmaceuticals Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | San Mateo | Stoughton | Raleigh | Stamford | Palatine |
| State/Province | California | Massachusetts | North Carolina | Connecticut | Illinois |
| No. of Employees | 15 | 197 | - | 55 | 14 |
| Entity Type | Public | Public | Private | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Adrian Adams | Chairman | Executive Board | 2013 | 72 |
| Vincent J. Angotti | Chief Executive Officer; Director | Executive Board | 2017 | 55 |
| Raffi Asadorian | Chief Financial Officer | Senior Management | 2017 | 53 |
| Pamela P. Palmer, M.D, Ph.D. | Chief Medical Officer; Co-Founder | Senior Management | 2005 | 60 |
| Badri Dasu | Chief Engineering Officer | Senior Management | 2007 | 60 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward